Next Quarterly Earnings
Thursday, November 5, 2026
CW 45
After-Hours
In 70 days
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a US-based biopharmaceutical company dedicated to the development and commercialization of allogeneic cell therapies. The company leverages pluripotent stem cells to research and clinically develop innovative regenerative medicine solutions for serious diseases, focusing on creating novel treatment options.
Frequently asked questions
When will Lineage Cell Therapeutics report its next quarterly earnings?
Lineage Cell Therapeutics is scheduled to report its next quarterly earnings on 11/05/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
When did Lineage Cell Therapeutics last report quarterly earnings?
Lineage Cell Therapeutics last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.03 USD.
How does Lineage Cell Therapeutics stock react to earnings?
Across its last 3 earnings reports, Lineage Cell Therapeutics stock moved by ±3.1% on average the following day. The largest reaction was -5% on 11/05/2025; 1 of 3 reactions were positive.
How often has Lineage Cell Therapeutics beaten expectations?
Lineage Cell Therapeutics has beaten analyst EPS estimates in 1 of its last 3 evaluated quarters (beat rate: 33.3%).
How do I add the Lineage Cell Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±3.1%
Avg. next-day move
-5%
Largest move (11/05/2025)
33.3%
Share of positive reactions
±10%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
1/3
Quarters above estimates
33.3%
Beat rate
+18.8%
Avg. EPS surprise
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Lineage Cell Therapeutics
Country
🇺🇸
More Financial Information